In-silico analysis of multiepitope based vaccine targeting respiratory viruses SARS, MERS and SARS-CoV-2
暂无分享,去创建一个
Atiah H. Almalki | T. Bhardwaj | P. Somvanshi | S. Haque | B. Rathi | E. Janahi | A. Alsulimani | A. Sen | B. N. Tewari | Ritu Bansal | Sanika Mohagaonkar
[1] Fuxun Yu,et al. Contriving Multi-Epitope Subunit of Vaccine for COVID-19: Immunoinformatics Approaches , 2020, Frontiers in Immunology.
[2] Md. Shahedur Rahman,et al. Designing a multi-epitope vaccine against SARS-CoV-2: an immunoinformatics approach , 2020, Journal of biomolecular structure & dynamics.
[3] Amjad Ali,et al. Designing Multi-Epitope Vaccines to Combat Emerging Coronavirus Disease 2019 (COVID-19) by Employing Immuno-Informatics Approach , 2020, Frontiers in Immunology.
[4] F. Castiglione,et al. A candidate multi-epitope vaccine against SARS-CoV-2 , 2020, Scientific Reports.
[5] Colin Renfrew,et al. Phylogenetic network analysis of SARS-CoV-2 genomes , 2020, Proceedings of the National Academy of Sciences.
[6] Yumeng Yan,et al. The HDOCK server for integrated protein–protein docking , 2020, Nature Protocols.
[7] S. Bose,et al. Immunoinformatics‐aided identification of T cell and B cell epitopes in the surface glycoprotein of 2019‐nCoV , 2020, Journal of medical virology.
[8] Lanjuan Li,et al. Molecular Characteristics, Functions, and Related Pathogenicity of MERS-CoV Proteins , 2019, Engineering.
[9] Marc Hafner,et al. A Multi-center Study on the Reproducibility of Drug-Response Assays in Mammalian Cell Lines , 2019, Cell systems.
[10] T. Bhardwaj,et al. Comparative assessment of the therapeutic drug targets of C. botulinum ATCC 3502 and C. difficile str. 630 using in silico subtractive proteomics approach , 2019, Journal of cellular biochemistry.
[11] Jie Cui,et al. Origin and evolution of pathogenic coronaviruses , 2018, Nature Reviews Microbiology.
[12] R. Mandal,et al. Inhibition of C298S mutant of human aldose reductase for antidiabetic applications: Evidence from in silico elementary mode analysis of biological network model , 2018, Journal of cellular biochemistry.
[13] R. Mandal,et al. Aspartate‐β‐semialdeyhyde dehydrogenase as a potential therapeutic target of Mycobacterium tuberculosis H37Rv: Evidence from in silico elementary mode analysis of biological network model , 2018, Journal of cellular biochemistry.
[14] Wei Li,et al. ElliPro: a new structure-based tool for the prediction of antibody epitopes , 2008, BMC Bioinformatics.
[15] Wei Xu,et al. A chimeric multi-epitope DNA vaccine elicited specific antibody response against severe acute respiratory syndrome-associated coronavirus which attenuated the virulence of SARS-CoV in vitro , 2008, Immunology Letters.
[16] Krishna Shankara Narayanan,et al. SARS coronavirus accessory proteins , 2007, Virus Research.
[17] Morten Nielsen,et al. Large-scale validation of methods for cytotoxic T-lymphocyte epitope prediction , 2007, BMC Bioinformatics.
[18] Sudipto Saha,et al. Prediction of continuous B‐cell epitopes in an antigen using recurrent neural network , 2006, Proteins.
[19] John Sidney,et al. Predicting population coverage of T-cell epitope-based diagnostics and vaccines , 2006, BMC Bioinformatics.